Board of Directors
The Board of Directors of the Novo Nordisk Foundation has nine members, of which six are elected under the Articles of Association and three are employee elected board members. The Board has adopted a competence profile that describes the preferred competencies of the Board.

Lars Rebien Sørensen
Chairman

Marianne Philip
Vice Chair

Jakob Müller
Member

Lars Fugger
Member

Lars Munch
Member

Mads Grøn
Member

Liselotte Højgaard
Member

Steen Riisgaard
Member

Stig Strøbæk
Member
Our management

Mads Krogsgaard Thomsen
CEO, Professor, DVM, PhD, DSc

Petrina Knowles Gjelstrup
Chief People Officer

Søren Nedergaard
Chief Operating Officer

Hanna Line Jakobsen
Director of Social Programmes, MBA

Steffen P. Lüders
Senior Vice President, Corporate affairs

Claus Felby
Senior Vice President, Biotech, Professor, PhD

Lene Oddershede
Senior Vice President, Natural & Technical Sciences, Professor

Paul Chiasson
Senior Vice President, Finance & Digitalisation

Martin Ridderstråle
Senior Vice President, Medical Science, Chief Medical Officer

Ole Falvig Ramsby
Senior Vice President, Legal, Attorney-at-law, LLM

Berith Bjørnholm
Senior Vice President, Education & Outreach, PhD

Peter Lawætz Andersen
Senior Vice President, Infectious Disease, Professor, DVM, DSc

Arne Astrup
Senior Vice President, Obesity and Nutrition Science, professor, MD, DMSc

Thomas Alslev Christensen
Senior Vice President, Impact, PhD

Sofie Singbrant Söderberg
Director, Head of Project & Portfolio Management, PhD

Mikkel Skovborg
Senior Vice President, Innovation

Anne Kahr Hällman
Director, Grant Management, PhD